Mark S. Soloway
#94,981
Most Influential Person Now
Mark S. Soloway's AcademicInfluence.com Rankings
Mark S. Solowayphilosophy Degrees
Philosophy
#3584
World Rank
#5758
Historical Rank
Logic
#1255
World Rank
#1956
Historical Rank
Download Badge
Philosophy
Mark S. Soloway's Degrees
- Bachelors Biology University of Pennsylvania
Similar Degrees You Can Earn
Why Is Mark S. Soloway Influential?
(Suggest an Edit or Addition)Mark S. Soloway's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive molecular characterization of urothelial bladder carcinoma (2014) (1748)
- Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. (1992) (694)
- Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan (1988) (625)
- Active surveillance for prostate cancer: a systematic review of the literature. (2012) (585)
- Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. (1998) (384)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder. (2013) (378)
- Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. (2002) (328)
- Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. (1996) (321)
- Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. (2002) (297)
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer (1995) (295)
- A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. (1992) (287)
- A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. (2011) (280)
- Detection of bladder cancer using a point-of-care proteomic assay. (2005) (277)
- Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer. (2010) (274)
- Careful selection and close monitoring of low-risk prostate cancer patients on active surveillance minimizes the need for treatment. (2010) (268)
- Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer Group. (2016) (257)
- Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms (1984) (252)
- Urothelial susceptibility to tumor cell implantation influence of cauterization (1980) (247)
- Tumor-associated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer. (1997) (241)
- Quality of life: radical prostatectomy versus radiation therapy for prostate cancer. (1995) (230)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. (2013) (223)
- Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. (1987) (223)
- Current bladder tumor tests: does their projected utility fulfill clinical necessity? (2001) (219)
- Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. (2000) (218)
- Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. (2006) (217)
- Periprostatic local anesthesia before ultrasound guided prostate biopsy. (2000) (212)
- Patients' choice of treatment in stage D prostate cancer. (1989) (210)
- Contemporary management of stage T1 transitional cell carcinoma of the bladder. (2002) (204)
- Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. (2007) (203)
- Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. (1995) (199)
- Small cell carcinoma of the bladder and prostate. (1995) (198)
- Intravesical and systemic chemotherapy of murine bladder cancer. (1977) (189)
- Positive surgical margins with radical prostatectomy: detailed pathological analysis and prognosis. (1996) (188)
- Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience (2007) (188)
- Improved detection of recurrent bladder cancer using the Bard BTA stat Test. (1998) (184)
- Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. (2008) (182)
- A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. (2003) (180)
- Complications of intravesical therapy for urothelial cancer of the bladder. (2006) (179)
- Expectant management of small, recurrent, noninvasive papillary bladder tumors. (2003) (175)
- The Management of Superficial Bladder Cancer (1980) (175)
- Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. (2012) (174)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder. (2013) (173)
- Local anesthesia for ultrasound guided prostate biopsy: a prospective randomized trial comparing 2 methods. (2001) (171)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings. (2013) (165)
- Pathologic changes associated with androgen deprivation therapy for prostate cancer (1991) (163)
- Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group. (1995) (162)
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone (1983) (162)
- Quality of life 12 months after radical prostatectomy. (1995) (160)
- Muscle-invasive urothelial carcinoma of the bladder. (2007) (160)
- Susceptibility of urothelium to neoplastic cellular implantation. (1975) (154)
- Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. (1999) (151)
- Rationale for intensive intravesical chemotherapy for superficial bladder cancer. (1980) (151)
- Urethral recurrence following radical cystectomy. (1990) (144)
- Management of renal cell carcinoma with level III thrombus in the inferior vena cava. (2002) (141)
- Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer (2015) (140)
- Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group. (1997) (139)
- Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract. (1996) (137)
- The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. (2002) (137)
- Serial multiple-site biopsies in patients with bladder cancer. (1978) (136)
- Pathologic prostate cancer characteristics in patients eligible for active surveillance: a head-to-head comparison of contemporary protocols. (2012) (135)
- Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. (1991) (134)
- Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques. (2007) (134)
- Positive surgical margins after radical retropubic prostatectomy: the influence of site and number on progression. (2002) (133)
- Long-term survival in patients undergoing radical nephrectomy and inferior vena cava thrombectomy: single-center experience. (2010) (133)
- Photodynamic diagnosis in urology: state of the art. (2011) (131)
- Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer (2008) (128)
- The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group. (1992) (126)
- Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting. (2005) (125)
- Update on bladder neck preservation during radical retropubic prostatectomy: impact on pathologic outcome, anastomotic strictures, and continence. (1998) (125)
- Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests (2002) (124)
- Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? (2004) (122)
- Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy (1994) (121)
- Treatment with finasteride following radical prostatectomy for prostate cancer. (1995) (120)
- Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer. (2003) (117)
- Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. (2008) (116)
- A multi-institutional evaluation of active surveillance for low risk prostate cancer. (2013) (115)
- Anticoagulation and antiplatelet therapy in urological practice: ICUD/AUA review paper. (2014) (114)
- Liver transplantation techniques for the surgical management of renal cell carcinoma with tumor thrombus in the inferior vena cava: step-by-step description. (2011) (110)
- De novo muscle invasive bladder cancer: is there a change in trend? (2001) (109)
- Association of hyaluronic acid family members (HAS1, HAS2, and HYAL‐1) with bladder cancer diagnosis and prognosis (2011) (109)
- A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimens. (2013) (108)
- Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. (2006) (108)
- Clinical Practice Recommendations for the Prevention and Management of Intravesical Therapy-Associated Adverse Events. (2008) (108)
- Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer. (1986) (107)
- Clinical study of leuprolide depot formulation in the treatment of advanced prostate cancer. The Leuprolide Study Group. (1990) (106)
- Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. (1999) (106)
- Surgical techniques for treating a renal neoplasm invading the inferior vena cava. (2003) (106)
- Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscleinvasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette- Guérin (BCG): results of an international individual patient data survey (IPDS) (2013) (104)
- The use of liver transplant techniques to aid in the surgical management of urological tumors. (2000) (102)
- A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group. (1995) (102)
- Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition. (2014) (100)
- Diagnosis and management of superficial bladder cancer. (1989) (99)
- Prognostic significance of changes in prostate‐specific markers after endocrine treatment of stage D2 prostatic cancer (1992) (98)
- Secondary cancer after radiotherapy for prostate cancer: should we be more aware of the risk? (2007) (97)
- Clinical and demographic characteristics associated with prostate cancer progression in patients on active surveillance. (2012) (96)
- The impact of current staging procedures in assessing disease extent of prostatic adenocarcinoma. (1979) (95)
- BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG (2017) (95)
- Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL‐1), CD44v6 and microvessel density for prostate cancer (2004) (94)
- Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancer. (1989) (94)
- Limitations of biopsy Gleason grade: implications for counseling patients with biopsy Gleason score 6 prostate cancer. (2004) (94)
- Quality of life and psychosocial status in stage D prostate cancer (1992) (93)
- Complications of advanced prostate cancer. (1999) (93)
- Risk of positive margins and biochemical recurrence in relation to nerve-sparing radical prostatectomy. (2002) (92)
- „NORMAL”︁ urothelium in patients with bladder cancer. A preliminary report from the national bladder cancer collaborative group a (1979) (89)
- A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a study (1983) (88)
- Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer. (2001) (87)
- Renal carcinoma with supradiaphragmatic tumor thrombus: avoiding sternotomy and cardiopulmonary bypass. (2010) (87)
- Regulation of Hyaluronidase Activity by Alternative mRNA Splicing* (2002) (87)
- Chemotherapy Programs of the National Prostatic Cancer Project (NPCP) (1980) (86)
- Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients (2008) (84)
- Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer. (2014) (83)
- Histopathological effects of androgen deprivation in prostatic cancer. (1996) (83)
- Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. (2010) (83)
- Fournier's syndrome: synergistic gangrene of the scrotum. (1975) (82)
- Cis‐diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer (1981) (81)
- Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. (2011) (78)
- Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. (1983) (77)
- Smoking and Bladder Cancer: A Systematic Review of Risk and Outcomes. (2015) (76)
- The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? (2003) (75)
- Transitional cell carcinoma of the prostate. (1991) (75)
- "Complete transurethral resection of bladder tumor": are the guidelines being followed? (2010) (74)
- Immunohistochemical evidence of the existence and localization of aromatase in human prostatic tissues (1992) (74)
- Bladder neck preservation and its impact on positive surgical margins during radical prostatectomy. (1993) (73)
- Cyclooxygenase‐2 (cox‐2) expression is an independent predictor of prostate cancer recurrence (2006) (73)
- The effect of mitomycin C on superficial bladder cancer. (1981) (72)
- Development and multi‐institutional validation of an upgrading risk tool for Gleason 6 prostate cancer (2013) (71)
- Marital satisfaction of advanced prostate cancer survivors and their spousal caregivers: the dyadic effects of physical and mental health (2011) (70)
- Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. (1996) (70)
- Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients (1995) (68)
- Radiation Therapy and cis-diammine-dichloroplatinum (II) in transplantable and primary murine bladder cancer. (1979) (68)
- Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited. (2000) (68)
- A multi-institutional evaluation of active surveillance for low risk prostate cancer. (2009) (68)
- Cisplatin and full dose irradiation for patients with invasive bladder carcinoma: a preliminary report of tolerance and local response. (1984) (67)
- Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8 (2003) (67)
- HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer. (2010) (67)
- Renal cell carcinoma with tumor thrombus extending above diaphragm: avoiding cardiopulmonary bypass. (2005) (66)
- Osteopontin and Interleukin-8 Expression is Independently Associated with Prostate Cancer Recurrence (2008) (66)
- Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. (2010) (65)
- Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome (2009) (64)
- Perceived stress mediates the effects of social support on health-related quality of life among men treated for localized prostate cancer. (2010) (64)
- Screening for bladder cancer: rationale, limitations, whom to target, and perspectives. (2013) (64)
- Intraoperative cell salvage during radical cystectomy does not affect long-term survival. (2007) (64)
- The diagnosis and staging of bladder cancer: from RBCs to TURs. (2006) (62)
- Bladder neck preservation following radical prostatectomy: continence and margins. (1995) (61)
- Metastatic melanoma of the gallbladder. (1972) (61)
- Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate. (1981) (61)
- Active surveillance vs. treatment for low-risk prostate cancer: a cost comparison. (2013) (60)
- Randomized prospective study comparing radical prostatectomy alone versus radical prostatectomy preceded by androgen blockade in clinical stage B2 (T2bNxM0) prostate cancer. The Lupron Depot Neoadjuvant Prostate Cancer Study Group. (1995) (60)
- Re: Schrier BPh, Hollander MP, van Rhijn BWG, Kiemeney LALM, Witjes JA. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 2004;45:292-6. (2005) (60)
- Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. (2003) (60)
- The diagnostic value of urine versus bladder washing in patients with bladder cancer. (1981) (59)
- Renal cell carcinoma invading the hepatic veins (2001) (59)
- Side Effects Associated with Intravesical Mitomycin C (1981) (59)
- Bladder-neck preservation during radical retropubic prostatectomy. (2000) (59)
- The Importance of Prognostic Factors in Advanced Prostate Cancer (1990) (58)
- Current bladder cancer tests: unnecessary or beneficial? (2003) (58)
- Bladder cancer: Lack of progress in bladder cancer—what are the obstacles? (2013) (57)
- INDEPENDENT PROGNOSTIC FACTORS IN PATIENTS WITH METASTATIC (STAGBE D2) PROSTATE CANCER (1991) (56)
- CasodexTM 10–200 mg Daily, Used as Monotherapy for the Treatment of Patients with Advanced Prostate Cancer (1998) (56)
- Upper tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: incidence and risk factors (2004) (56)
- Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. (2005) (56)
- Does cyclophosphamide induce bladder cancer? (1978) (55)
- Overview of treatment of superficial bladder cancer. (1986) (54)
- Bland thrombus association with tumour thrombus in renal cell carcinoma: analysis of surgical significance and role of inferior vena caval interruption (2012) (54)
- A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area. (1983) (54)
- Assessment of endpoints for clinical trials for localized prostate cancer. (1997) (54)
- Periprostatic Local Anesthesia before Ultrasound–Guided Prostate Biopsy: An Update of the Miami Experience (2001) (54)
- Selective urethrectomy following cystoprostatectomy for bladder cancer. (1986) (53)
- Cigarette smoking: A review of possible associations with benign prostatic hyperplasia and prostate cancer (1993) (52)
- Zoladex versus orchiectomy in treatmentof advanced prostate cancer: a randomized trial (1991) (52)
- Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate. (1979) (52)
- Pathological changes associated with topical chemotherapy for superficial bladder cancer. (1981) (50)
- HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer. (2006) (50)
- Sexual, psychological and dyadic qualities of the prostate cancer ‘couple’ (2005) (50)
- Safety and efficacy of an implantable leuprolide delivery system in patients with advanced prostate cancer. (2000) (50)
- HAS1 expression in bladder cancer and its relation to urinary HA test (2007) (49)
- Sampling of radical prostatectomy specimens. How much is adequate? (1994) (49)
- Cis-diamminedichloroplatinum II in advanced urothelial cancer. (1978) (49)
- Single and combination chemotherapy for primary murine bladder cancer (1975) (48)
- Bladder cancer after radiotherapy for prostate cancer: detailed analysis of pathological features and outcome after radical cystectomy. (2008) (48)
- Effect of chemotherapeutic agents on bladder cancer: a new animal model. (1973) (48)
- Experimental chemotherapy of bladder cancer--systemic and intravesical. (1979) (48)
- Invasive bladder cancer: support for screening. (1983) (48)
- Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients. (1995) (47)
- Should the followup of patients with bladder cancer include routine excretory urography? (1983) (47)
- Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets (2017) (47)
- Comparison of goserelin and leuprolide in combined androgen blockade therapy. (1998) (45)
- Radical prostatectomy: is complete resection of the seminal vesicles really necessary? (1996) (44)
- Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus (2005) (44)
- Early ligation of the renal artery using the posterior approach: a basic surgical concept reinforced during resection of large hypervascular renal cell carcinoma with or without inferior vena cava thrombus (2003) (43)
- Prognostic factors in patients with advanced prostate cancer. (1989) (43)
- Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group. (1996) (43)
- Value of urine cytology versus bladder washing in bladder cancer. (1992) (43)
- Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy (2007) (42)
- Treatment of superficial bladder cancer with intravesical mitomycin C: analysis of immediate and long-term response in 70 patients. (1985) (42)
- Clinical Practice Recommendations for the Management of Non–Muscle Invasive Bladder Cancer (2008) (42)
- Transrectal ultrasound for staging prior to radical prostatectomy. (1989) (42)
- Urothelial dysplasia. (1982) (41)
- Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogen (1993) (41)
- A pelvic drain can often be avoided after radical retropubic prostatectomy--an update in 552 cases. (2006) (41)
- Introduction and overview of intravesical therapy for superficial bladder cancer. (1988) (41)
- The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. (1979) (40)
- Antiandrogenic agents as monotherapy in advanced prostatic carcinoma (1993) (40)
- Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence. (2009) (40)
- En bloc mobilization of the pancreas and spleen to facilitate resection of large tumors, primarily renal and adrenal, in the left upper quadrant of the abdomen: techniques derived from multivisceral transplantation. (2009) (40)
- Mitomycin c intravesical therapy in noninvasive bladder cancer after failure on thiotepa (1984) (40)
- Prostate sampling by 12-core biopsy: comparison of the biopsy results with tumor location in prostatectomy specimens. (2012) (40)
- Instillation of bacillus Calmette-Guerin into the renal pelvis of a solitary kidney for the treatment of transitional cell carcinoma. (1990) (40)
- A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. (1981) (40)
- Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report. (1982) (39)
- Quality of life and psychosocial status in stage D prostate cancer. Zoladex Prostate Cancer Study Group. (1992) (39)
- Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C. (1987) (39)
- Epigenetic Regulation of HYAL-1 Hyaluronidase Expression (2008) (39)
- Radical cystectomy after bacillus Calmette-Guérin for high-risk Ta, T1, and carcinoma in situ: defining the risk of initial bladder preservation. (2006) (39)
- Prognostic factors in metastatic prostate cancer (1993) (38)
- Primary carcinoma of male urethra. (1984) (38)
- Experience with weekly doxorubicin (adriamycin) in hormone-refractory stage D2 prostate cancer. (1992) (38)
- Early prostate cancer: prevention, treatment modalities, and quality of life issues. (2003) (38)
- Serum Free Circulating DNA Is a Useful Biomarker to Distinguish Benign versus Malignant Prostate Disease (2010) (38)
- Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosourea. (1983) (38)
- Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis. (2012) (38)
- It is time to abandon the "superficial" in bladder cancer. (2007) (37)
- Optimal management of the T1G3 bladder cancer. (2005) (37)
- Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature (2018) (37)
- Summary of workshop on carcinoma in situ of the bladder. (1986) (37)
- Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study (2007) (36)
- Bladder cancer induced by noncarcinogenic substances. (1984) (36)
- Expectant treatment of small, recurrent, low-grade, noninvasive tumors of the urinary bladder. (2006) (35)
- Small cell carcinoma of the bladder (2004) (35)
- A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone–Releasing hormone analogue therapy, in patients with advanced prostate carcinoma: Analysis of time to progression (1996) (35)
- Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells. (1998) (35)
- Failure after radical prostatectomy. (2003) (35)
- Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report. (1980) (34)
- Venous thromboembolism in radical prostatectomy: is heparinoid prophylaxis warranted? (2005) (34)
- Thiotepa-induced myelosuppression: review of 670 bladder instillations. (1983) (34)
- Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder. (1988) (34)
- PSA levels and the rate of positive surgical margins in radical prostatectomy specimens preceded by androgen blockade in clinical B2 (T2bNxMo) prostate cancer. The Lupron Depot Neoadjuvant Study Group. (1997) (33)
- Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer (2018) (33)
- The morphologic effects of mitomycin c in mammalian urinary bladder (1981) (33)
- Renal cell cancer with invasive atrial tumor thrombus excised off-pump. (2005) (32)
- Radical prostatectomy alone vs radical prostatectomy preceded by androgen blockade in CT2B prostate cancer -24 month results (1997) (32)
- Selecting initial therapy for bladder cancer (1987) (32)
- Prophylaxis of bladder tumor implantation. Intravesical and systemic chemotherapy. (1976) (32)
- Impact of 2004 ISUP/WHO classification on bladder cancer grading (2015) (31)
- Comprehensive analysis of post‐diagnostic prostate‐specific antigen kinetics as predictor of a prostate cancer progression in active surveillance patients (2013) (31)
- Is there a role for digital rectal examination in the followup of patients after radical prostatectomy? (1999) (31)
- Should we abandon the FISH test? (2007) (30)
- Failure of ascorbic acid to inhibit FANFT-induced bladder cancer. (1975) (30)
- The importance of transurethral resection in managing patients with urothelial cancer in the bladder: proposal for a transurethral resection of bladder tumor checklist. (2012) (30)
- A pelvic drain may be avoided after radical retropubic prostatectomy. (2003) (30)
- Age as a prognostic factor for disease recurrence after radical prostatectomy. (1999) (30)
- Managing superficial bladder cancer: an overview. (1992) (30)
- Risk‐adapted management of low‐grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG) (2020) (30)
- Casodex 10-200 mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. An overview of the efficacy, tolerability and pharmacokinetics from three phase II dose-ranging studies. Casodex Study Group. (1998) (30)
- Current Approaches to the Management of Non-Muscle Invasive Bladder Cancer : Comparison of Current Guidelines and Recommendations (2008) (30)
- In vitro characterization of four N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide (FANFT) induced mouse bladder tumors. (1982) (29)
- Nephrogenic adenoma. (1987) (29)
- Intravesical and systemic chemotherapy in the management of superficial bladder cancer. (1984) (29)
- Flexible cystourethroscopy: alternative to rigid instruments for evaluation of lower urinary tract. (1985) (28)
- Serial spot hydroxyproline/creatinine ratios in metastatic prostatic cancer. (1983) (28)
- The Use of Natural Veno-Venous Bypass during Surgical Treatment of Renal Cell Carcinoma with Inferior Vena Cava Thrombus (2002) (28)
- Office evaluation and management of bladder neoplasms. (1998) (28)
- Anuria following silver nitrate irrigation for intractable bladder hemorrhage. (1977) (28)
- Basal cell carcinoma of the prostate: current concepts (2007) (28)
- Vascular stapling of the inferior vena cava: further refinement of techniques for the excision of extensive renal cell carcinoma with unresectable vena-caval involvement. (2009) (28)
- Ileal conduit exfoliative cytology in the diagnosis of recurrent cancer. (1972) (28)
- Stage T1A carcinoma of prostate. (1994) (28)
- Association of Stress Management Skills and Perceived Stress with Physical and Emotional Well-Being Among Advanced Prostrate Cancer Survivors Following Androgen Deprivation Treatment (2013) (28)
- Chemotherapy of experimental transitional-cell carcinoma. (1974) (28)
- Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer. (1994) (28)
- 1010 HEXVIX® FLUORESCENCE CYSTOSCOPY IMPROVES DETECTION AND RESECTION OF PAPILLARY BLADDER CANCER AND REDUCES EARLY RECURRENCE: A MULTICENTRE, PROSPECTIVE, RANDOMIZED STUDY (2009) (27)
- Do we have a prostate specific antigen for bladder cancer? (1999) (27)
- Pre-treatment testosterone levels: significance in androgen deprivation therapy. (1986) (27)
- Circadian and day-to-day variation of prostatic acid phosphatase. (1982) (27)
- Clinical parameters outperform molecular subtypes for predicting outcome in bladder cancer: Results from multiple cohorts including TCGA. (2019) (27)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Urothelial carcinoma of the prostate. (2013) (26)
- The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer. (1999) (26)
- A controlled trial of Casodex (bicalutamide) vs. flutamide, each in combination with luteinising hormone-releasing hormone analogue therapy in patients with advanced prostate cancer. Casodex Combination Study Group. (1996) (26)
- Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy. (2012) (26)
- Prostate cancer progression after therapy of primary curative intent (2005) (26)
- Intravesical therapy for bladder cancer (2010) (26)
- Malignant fibrous histiocytoma of the kidney. (1980) (26)
- Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer. (2020) (25)
- Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities. (1984) (25)
- Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours. (2020) (25)
- How reliable is a single measurement of urinary flow in the diagnosis of obstruction in benign prostatic hyperplasia? (1993) (25)
- Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide. (1995) (25)
- Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II multicenter trial. (1996) (24)
- Intraoperative T staging in radical retropubic prostatectomy: is it reliable? (2001) (24)
- Epigenetic targets in the diagnosis and treatment of prostate cancer. (2007) (24)
- Superficial bladder cancer: Diagnosis, surveillance and treatment (1992) (24)
- High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder. (1997) (24)
- Deferred treatment of localized prostate cancer in the elderly: the impact of the age and stage at the time of diagnosis on the treatment decision (2000) (24)
- Do unto others--why I would want anesthesia for my prostate biopsy. (2003) (24)
- Lack of progress in early diagnosis of bladder cancer. (2007) (24)
- Prognostic significance of urine cytology on initial follow‐up after intravesical mitomycin C for superficial bladder cancer (1986) (24)
- Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. (1989) (23)
- Lymphovascular invasion in radical cystectomy specimen: is it an independent prognostic factor in patients without lymph node metastases? (2009) (23)
- Intravesical therapy for bladder cancer. (1988) (23)
- Is the incidence of uretero‐intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? (2010) (23)
- Bicalutamide in the treatment of advanced prostatic carcinoma: a phase II noncomparative multicenter trial evaluating safety, efficacy and long-term endocrine effects of monotherapy. (1995) (23)
- Intraoperative cell salvage during radical prostatectomy: a safe technique for Jehovah's Witnesses. (2004) (22)
- Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models (2013) (22)
- Fibroepithelial polyp of the renal pelvis: nephron-sparing surgery after false-positive biopsy for transitional cell carcinoma. (1997) (22)
- Buserelin as primary therapy in advanced prostatic carcinoma (1985) (22)
- In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines. (1992) (22)
- Eliminate the term "superficial" bladder cancer. (2006) (22)
- Comparative validation of nomograms predicting clinically insignificant prostate cancer. (2013) (22)
- Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable? (1984) (21)
- Partial Sampling of Radical Prostatectomy Specimens: Detection of Positive Margins and Extraprostatic Extension (2013) (21)
- Oncologic outcomes following radical prostatectomy with intraoperative cell salvage (2012) (21)
- Initial evaluation and response criteria for patients with superficial bladder cancer. Report of a workshop. (1990) (21)
- Developing carcinoma (dysplasia) of the urinary bladder. (1982) (21)
- Radical cystectomy and adjuvant chemotherapy. (1985) (21)
- Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues (1999) (21)
- Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study Group. (1991) (21)
- Difficult decisions in urologic oncology: management of high-grade T1 transitional cell carcinoma of the bladder. (2007) (20)
- The effect of thio‐TEPA on developing and established mammalian bladder tumors (1980) (20)
- Does body mass index affect outcome after reconstruction of orthotopic neobladder? (2007) (20)
- Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists (2011) (20)
- Buserelin treatment of advanced prostatic carcinoma long‐term follow‐up of antitumor responses and improved quality of life (1987) (20)
- Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3‐year experience (2006) (20)
- Intravesical therapy for bladder cancer. (1994) (20)
- Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens (2013) (19)
- Subsequent tumor analysis of 36 patients who have received intravesical mitomycin C for superficial bladder cancer. (1983) (19)
- Cis-diamminedichloroplatinum (II) in advanced bladder cancer (1978) (19)
- Regional lymphadenectomy and tumor immunity. (1976) (19)
- Active surveillance for low-risk bladder cancer. (2014) (19)
- The use of video-based patient education for shared decision-making in the treatment of prostate cancer. (2000) (19)
- Outcome after radical cystectomy in patients with clinical T2 bladder cancer in whom neoadjuvant chemotherapy has failed (2009) (19)
- Liver Transplantation Techniques with Preservation of the Natural Venovenous Bypass: Effect on Surgical Resection of Renal Cell Carcinoma Invading the Inferior Vena Cava (2004) (19)
- Techniques for Avoidance of Sternotomy and Cardiopulmonary Bypass During Resection of Extensive Renal Cell Carcinoma with Vena Caval Tumor Thrombus Extension Above the Diaphragm (2009) (18)
- The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder (2005) (18)
- Mitomycin for patients who have failed on thiotepa. The National Bladder Cancer Group. (1985) (18)
- Diagnosis and Treatment of Bladder Cancer: How Can We Improve? (2012) (18)
- Response to second-line hormonal manipulation monitored by serum PSA in stage D2 prostate carcinoma. (1992) (18)
- Metastatic adenoid cystic carcinoma to the kidney in a young woman. (2006) (18)
- The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group. (1990) (18)
- Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures. (2005) (18)
- Prostate cancer after heart transplantation. (1995) (18)
- Total and nondialyzable hydroxyproline excretion in stage D2 prostate cancer (1984) (17)
- Progression and survival in patients with T1G3 bladder tumors. (2002) (17)
- Visual estimate of percent of carcinoma predicts recurrence after radical prostatectomy. (2003) (17)
- Evaluation of analgesic requirements and postoperative recovery after radical retropubic prostatectomy using long-acting spinal anesthesia. (2005) (16)
- Malignant penile horn. (1977) (16)
- Leiomyosarcoma of the bladder and subsequent urethral recurrence. (1981) (16)
- Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis (2012) (16)
- The clonogenic growth of cells derived from bladder barbotage in patients with transitional cell carcinoma of the bladder: a preliminary report. (1982) (16)
- Surgical techniques for endoscopic resection of bladder cancer. (1992) (16)
- Is adjuvant chemotherapy for bladder cancer safer in patients with an ileal conduit than a neobladder? (2005) (15)
- Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring. (2004) (15)
- Growth characteristics of N‐[4‐(5‐nitro‐2‐furyl)‐2‐thiazolyl]‐formamide (FANFT)‐induced mouse bladder tumor lines in a human tumor stem cell assay (1982) (15)
- Cyclophosphamide, doxorubicin hydrochloride and 5-fluorouracil in advanced carcinoma of the prostate. (1979) (15)
- Epithelioid leiomyoma of the bladder: an unusual cause of voiding symptoms. (1998) (15)
- Optical dilator to obviate blind urethral dilatation prior to endoscopic resections. (1988) (14)
- Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma. (1976) (14)
- Prognostic factors in superficial bladder cancer. (1986) (14)
- The risk and prophylactic management of bladder cancer after various forms of radiotherapy (2009) (14)
- A randomized controlled clinical trial of leuprolide and anandron versus leuprolide and placebo for advanced prostate cancer (1990) (14)
- Bilateral epidermoid cysts of the testis. (1996) (14)
- Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results. (1996) (14)
- Evaluation of urinary cytology as an indicator of bladder neoplasia in mice. (1973) (14)
- Intravesical therapy for transitional cell carcinoma of the bladder: the community practice. (1999) (14)
- [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]. (2001) (14)
- The addition of chemotherapy to hormonal therapy for treatment of patients with metastatic carcinoma of the prostate (1983) (14)
- Carcinogenesis in mammalian urothelium: changes induced by non-carcinogenic substances and chronic indwelling catheters. (1986) (14)
- Clinically significant Gleason sum upgrade (2012) (14)
- Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms. (1980) (14)
- Combined androgen blockade: an optimal therapy for minimally advanced prostate cancer? (1998) (14)
- Tumor focality is not associated with biochemical outcome after radical prostatectomy (2012) (13)
- Radical cystectomy for BCG failure: has the timing improved in recent years? (2011) (13)
- The use of urine-based biomarkers in bladder cancer. (2006) (13)
- Concurrent radical retropubic prostatectomy and inguinal hernia repair through a modified Pfannenstiel incision (2004) (13)
- Transurethral Resection of Bladder Cancer (1997) (13)
- Differential expression of SDF-1 isoforms in bladder cancer. (2014) (13)
- ICUD-EAU International Consultation on Bladder Cancer 2012: Recommendations on bladder cancer-progress in a cancer that lacks the limelight. (2013) (13)
- The clinical value of urinary carcinoembryonic antigen-like substances in urothelial cancer. (1977) (13)
- Transitional cell carcinoma of the prostate: Diagnosis, staging and management (1988) (13)
- Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival? (1993) (13)
- Tumor thrombus involving the inferior vena cava in renal malignancy: is there a difference in clinical presentation and outcome among right and left side tumors? (2009) (13)
- European Association of Urology and American Urological Association/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors. (2017) (12)
- Chemotherapy programs of the National Prostatic Cancer Project (NPCP). (1980) (12)
- Retroperitoneal fibrosis and aortic aneurysm. (1980) (12)
- Does pericapsular lignocaine reduce pain during transrectal ultrasonography‐guided biopsy of the prostate? (2003) (12)
- Hemospermia and expressed tumor in the urethra: an unusual presentation of ductal carcinoma of the prostate. (2000) (12)
- Contemporary open partial nephrectomy is associated with diminished procedure-specific morbidity despite increasing technical challenges: a single institutional experience (2010) (12)
- The stability and antitumor activity of recycled (intravesical) mitomycin C (1984) (12)
- Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery. (2012) (12)
- Cytology of ileal conduit urine. (1971) (12)
- Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer (2018) (12)
- Incidental appendectomy during radical cystectomy: an interdepartmental survey and review of the literature. (2000) (12)
- Blood Borne Metastases to the Kidney (1972) (12)
- Evaluation and management of patients with superficial bladder cancer. (1987) (12)
- 957 Long-term reduction in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy (2012) (12)
- Histopathologic evaluation of response to treatment of human tumors grown in the nude mouse. (1983) (12)
- Improving risk stratification in patients with prostate cancer managed by active surveillance: a nomogram predicting the risk of biopsy progression (2013) (12)
- Use of the tumour colony assay in the evaluation of patients with bladder cancer. (1983) (11)
- Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II). (1982) (11)
- Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? (2010) (11)
- Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer. (1983) (11)
- Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) Over Time Among Men Treated for Localized Prostate Cancer (2013) (11)
- Progression and complications after external beam radiation therapy for carcinoma of prostate. (1989) (11)
- Oncological and functional outcomes following open radical prostatectomy: how patients may achieve the "Trifecta"? (2011) (11)
- Surgical management of large adrenal tumours: the University of Miami experience using liver transplantation techniques (2008) (11)
- The role of liver transplantation techniques in the surgical management of advanced renal urothelial carcinoma with or without inferior vena cava thrombus. (2009) (11)
- An orally active Amazonian plant extract (BIRM) inhibits prostate cancer growth and metastasis (2003) (10)
- Budd-Chiari syndrome in urology: Impact on nephrectomy for advanced renal cell carcinoma (2011) (10)
- Effectiveness of long-term chemotherapy and/or BCG on murine bladder cancer. (1978) (10)
- Invasive bladder cancer: selection of primary treatment. (1990) (10)
- HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY IMPROVES DETECTION AND RESECTION OF PAPILLARY BLADDER CANCER LESIONS AND REDUCES EARLY RECURRENCES (2009) (10)
- Immunogenicity of N-[-4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced bladder cancer. (1978) (10)
- Erattum: Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: Final report of a double-blind, randomized, multicenter trial (Urology (September 1997) 50 (330-336)) (1998) (10)
- Implantation of transitional tumor cells on the cauterized murine urothelial surface. Abstr. (1979) (10)
- Single and sequential combination intravesical chemotherapy of murine bladder cancer. (1982) (10)
- Modified Pfannenstiel approach for radical retropubic prostatectomy. (2004) (10)
- Monitoring of the upper urinary tract in patients with bladder cancer (2011) (10)
- Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells. (1978) (10)
- Tumour nephrectomy with vena cava thrombus (2006) (10)
- Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy (2010) (10)
- Is there a role for induction therapy for locally advanced bladder cancer? (1987) (10)
- Total prostatectomy within 6 weeks of a prostate biopsy: is it safe? (2010) (10)
- Bladder tumor markers, intravesical therapy and systemic chemotherapy. (2001) (9)
- Osteogenic differentiation associated with x-ray therapy for adenocarcinoma of the prostate gland. (1986) (9)
- Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivation. (1988) (9)
- Intravesical Chemotherapy for Superficial Bladder Cancer (1982) (9)
- Proximal stent displacement as complication of pigtail ureteral stent. (1979) (9)
- Treatment modalities in superficial bladder cancer. (1989) (9)
- Side effects associated with intravesical mitomycin. (1981) (9)
- Synchronous panniculectomy with stomal revision for obese patients with stomal stenosis and retraction (2010) (9)
- Signet ring cell carcinoma of a pulled-through sigmoid colon mimicking a primary invasive bladder tumor: case report and review of the literature. (2000) (9)
- Bladder cancer. Management of an increasingly common tumor. (1983) (8)
- Efficacy of terazosin in patients with benign prostatic hyperplasia. (1992) (8)
- Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer. (1998) (8)
- Chemoimmunotherapy of implanted murine bladder cancer. (1983) (8)
- Efficacy of Buserelin in Advanced Prostate Cancer and Comparison With Historical Controls (1988) (8)
- Editorial comment on: robotic-assisted laparoscopic radical cystectomy with extracorporeal urinary diversion: initial experience. (2008) (8)
- Molecular targeting of renal cell carcinoma by an oral combination (2020) (8)
- Intravesical Chemotherapy in the Treatment of Superficial Bladder Cancer (2001) (8)
- Estimated potency of casodex: A problematic design [1] (multiple letters) (1997) (8)
- Possible Interaction of Indomethacin and Warfarin (1978) (8)
- Buserelin as primary therapy in advanced prostatic carcinoma. (1985) (8)
- Impact of body mass index and tumor location on the incidence of benign histology at the time of nephron-sparing surgery (2012) (8)
- The effect of hormonal therapy on a transplantable renal cortical adenocarcinoma in syngeneic mice. (1973) (8)
- Upper urinary tract cancer--challenges for the urologist. (2007) (8)
- A MULTI-INSTITUTIONAL COHORT OF ACTIVE SURVEILLANCE FOR LOW-RISK LOCALIZED PROSTATE CANCER (2008) (8)
- Treatment of early prostate cancer. (1989) (8)
- Is there a role for induction androgen deprivation prior to radical prostatectomy? (1996) (8)
- Bicalutamide and Flutamide, Each in Combination with Luteinizing Hormone-Releasing Hormone Analogs, in Advanced Prostate Cancer: Exploratory Analysis of Impact of Extent of Disease by Bone Scan on Outcome (2000) (8)
- Systemic chemotherapy of murine bladder cancer. (1984) (8)
- Radiation therapy of experimental murine bladder cancer - synergism with cisplatinum diamminedichloride. (1977) (7)
- Radical retropubic prostatectomy in Hispanic patients (2004) (7)
- Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion (2012) (7)
- Surgical margin status does not affect overall survival following radical prostatectomy: a single institution experience with expectant management. (2012) (7)
- Salvage open radical prostatectomy after failed radiation therapy: a single center experience (2011) (7)
- Urothelial susceptibility to neoplastic cellular implantation. (1974) (7)
- The use of a tumor colony assay in predicting chemotherapeutic drug response in murine bladder cancer (1983) (7)
- 1082: Evaluation and Work-up of Hematuria among Primary Care Physicians in Miami-Dade County: An Anonymous Questionnaire-Based Survey (2007) (7)
- Surgical techniques in the management of patients with superficial bladder cancer. (1986) (7)
- Carcinoma of the female urethra: reassessment of modes of therapy. (1983) (7)
- Management of ureteral and renal pelvic recurrence after cystectomy. (1994) (7)
- Presentation and outcome following radical cystectomy in Hispanics with bladder cancer. (2008) (7)
- Total prostatectomy and lymph node dissection may be done safely without pelvic drainage: an extended experience of over 600 cases. (2009) (7)
- Approaching the optimal transurethral resection of a bladder tumor. (2014) (7)
- CISPLATIN ANALOGS AND COMBINATION CHEMOTHERAPY IN THE THERAPY OF MURINE BLADDER CANCER (1980) (7)
- Benign prostatic hyperplasia. Universal problem among aging men. (1988) (6)
- Neither α‐blocker therapy nor cystography is required before early catheter removal after radical prostatectomy (2005) (6)
- Bladder carcinoma: Where are the patient advocates? (2005) (6)
- Radical cystectomy in presence of fused "cake" kidney. (1987) (6)
- Prognostic significance of cystoscopy findings following neoadjuvant chemotherapy for muscle-invasive bladder cancer. (2015) (6)
- Newer methods of hormonal therapy for prostate cancer. (1984) (6)
- Prostate Cancer and the Increasing Role of Active Surveillance (2013) (6)
- Learning to integrate systemic chemotherapy into a treatment plan for patients with advanced bladder cancer. (1985) (6)
- Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods. (2013) (6)
- Superficial bladder cancer: comments on evaluation and management. (1984) (6)
- Timing of androgen deprivation for prostate cancer: benefits versus side effects--a patient-physician dialogue. (2002) (6)
- Lymphocytic reaction associated with bladder cancer. Effect of chronic immunosuppression. (1974) (6)
- Diaminedichloroplatinum (DDP) VS. DDP plus cyclophosphamide (CY) for metastatic bladder carcinoma. A national bladder cancer collaborative group A (NBCCGA) study (1981) (6)
- It's not a radical prostatectomy, it's a total prostatectomy. (2008) (6)
- Where are the ‘poster boys’ for bladder cancer? (2003) (6)
- Hematocolpos with urinary tract obstruction in an adult. (1977) (6)
- Metastatic characteristics of four FANFT-induced murine bladder tumors. (1983) (6)
- Thromboembolism prophylaxis and total prostatectomy: is pharmacologic therapy required? (2008) (5)
- Diffuse large B cell lymphoma of the spermatic cord: a case report and literature review. (2012) (5)
- MP13-07 IMPROVED EFFICACY OF ADJUVANT, SINGLE DOSE INTRAVESICAL APAZIQUONE BY TIMING POST-RESECTION IN TWO DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 STUDIES IN NON-MUSCLE INVASIVE BLADDER CANCER (2016) (5)
- Platinum kinetics in patients treated with cis-dichlorodiammine platinum (II). (1982) (5)
- DUROS [trade mark sign] LEUPROLIDE IMPLANTABLE THERAPEUTIC SYSTEMS IN PATIENTS WITH ADVANCED PROSTATE CANCER: 14-MONTH RESULTS OF A PHASE I/II DOSE-RANGING STUDY (1999) (5)
- Re: overdiagnosis and overtreatment in cancer: an opportunity for improvement. (2014) (5)
- PD11-07 INTEGRATED RESULTS OF TWO MULTICENTER, RANDOMIZED, PLACEBO CONTROLLED, DOUBLE BLIND, PHASE 3 TRIALS (SPI-611/612) OF SINGLE-DOSE INTRAVESICAL APAZIQUONE IMMEDIATELY FOLLOWING RESECTION IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (2016) (5)
- Prostate Cancer: Localized VIIModerated Poster 511741 CAREFUL SELECTION AND CLOSE MONITORING OF LOW-RISK PROSTATE CANCER PATIENTS ON AN ACTIVE SURVEILLANCE PROTOCOL MINIMIZES THE NEED FOR TREATMENT (2010) (5)
- The Increasing Use of Liver Transplantation Surgical Techniques in the Management of Renal and Nonrenal Cancer With or Without Inferior Vena Cava Tumor Thrombus (2009) (5)
- Estramustine phosphate--hormone, chemotherapeutic agent, or both? (1984) (5)
- Urinary Cytology: Manual and Atlas (1992) (5)
- The importance of pretreatment testosterone and other prognostic variables in the response to androgen deprivation therapy. (1990) (5)
- The role of induction androgen deprivation prior to radical prostatectomy. (1996) (4)
- Re: Urine based markers of urological malignancy. (2002) (4)
- Adjuvant chemotherapy for locally advanced bladder cancer (1985) (4)
- Follow up of patients receiving treatment for superficial bladder cancer with mitomycin C and BCG. (1990) (4)
- Point. Routine use of postoperative intravesical chemotherapy after TURBT-should it be done? (2010) (4)
- Frozen sections for positive margins? (2006) (4)
- 1665: Lymphovascular Invasion in Bladder Cancer - Is it an Important Prognostic Indicator? (2007) (4)
- Does invasive bladder cancer differ between women and men? (1988) (4)
- Modified Pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience (2008) (4)
- Giant neobladder stone (2014) (4)
- Management Strategies for Patients with Locally Advanced Prostate Cancer (1999) (4)
- Intravesical and Systemic Chemotherapy (1976) (4)
- How can we improve outcomes for upper tract urothelial carcinoma? (2012) (4)
- Use of tumor colony assay in clinical oncology. (1983) (4)
- Renography in the evaluation of patients with ileal conduits. (1972) (4)
- Re: embryonal carcinoma of the testis in elderly men. (1978) (4)
- Active Surveillance or Office Fulguration for Low Grade Ta Bladder Tumors: A Win-Win for Patients and Urologists. (2017) (4)
- Expectant Management of Low-Risk Bladder Cancer (2015) (4)
- Editorial: Bladder cancer. How can we make a difference? (2003) (4)
- [Bladder tumors]. (1981) (4)
- Morbidity of modified pelvic lymphadenectomy and radiotherapy for prostatic cancer. (1991) (4)
- Editorial Comment: Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence (1996) (4)
- Significance of androgen deprivation prior to radical prostatectomy, with special reference to prostate-specific antigen (1993) (4)
- Radioisotope renography in patients with an ileal conduit: the importance of the sitting position. (1972) (3)
- In vitro and in vivo activity of two second generation platinum analogs in murine bladder cancer. (1985) (3)
- Diagnosis of Non-Muscle Invasive Bladder Cancer (2008) (3)
- Small cell carcinoma of the bladder in transplant recipients: a report of 2 cases. (2013) (3)
- "Definitive therapy" for cancer: is our message clear? (2010) (3)
- Prostatic pathology after androgen blockade: Effects on prostatic carcinoma and on nontumor prostate (1996) (3)
- EFFECTIVENESS OF VALRUBICIN IN PATIENTS WITH BCG-REFRACTORY CARCINOMA IN SITU OF THE BLADDER (1999) (3)
- Report of the 1991 International Meeting on Fundamental and Clinical Research in Urogenital Cancer. (1992) (3)
- The evaluation and follow-up of patients with Ta, Tcis, and T1 bladder cancer (2004) (3)
- Comparison of single agent cisplatin and cisplatin containing combinations in treatment of murine bladder cancer. (1987) (3)
- Bladder cancer: Active surveillance for low-grade Ta bladder tumours (2016) (3)
- 'Acute on chronic' effect of depot leuprolide in patients with stage D2 cancer of prostate. (1990) (3)
- M‐ VAC or MVC for the treatment of advanced transitional cell carcinoma: Metastatic, induction, and adjuvant (1989) (3)
- TOTAL PROSTATECTOMY WITHIN 6 WEEKS OF PROSTATE BIOPSY: IS SURGERY COMPROMISED? (2009) (3)
- Morphologic effects of thio-TEPA on mouse urothelium. (1977) (3)
- Editorial comment on: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. (2008) (3)
- ENDOLUMINAL OCCLUSION OF THE INFERIOR VENA CAVA IN RENAL CELL CARCINOMA WITH RETRO‐ OR SUPRAHEPATIC CAVAL THROMBUS (2006) (3)
- Chemotherapy of murine bladder cancer: in vitro and in vivo. (1984) (3)
- 456 A randomized double-blind trial in 813 previously untreated metastatic prostate cancer (CaP) patients (PTS) comparing a new antiandrogen casodex® (bicalutamide) with eulexin (flutamide) in combination with luteinizing hormone releasing hormone analogue (LHRH-a) therapy (1995) (3)
- Role of Patient-Physician Dialogue in Selecting the Type of Urinary Diversion (2010) (3)
- Evidence against a vesicorenal reflex. (1972) (3)
- Surgery and intravesical chemotherapy in the management of superficial bladder cancer. (1983) (3)
- [Future prospects for primary hormone therapy in localized and locally advanced prostate cancer]. (2003) (2)
- 703 ENHANCEMENT CHARACTERISTICS ON 4 PHASE DEDICATED RENAL PROTOCOL CT HELPS TO DISTINGUISH BENIGN FROM MALIGNANT TUMORS (2011) (2)
- MP28-17 DIFFERENTIAL EXPRESSION OF STROMA DERIVED FACTOR-1 ISOFORMS IN BLADDER CANCER (2014) (2)
- Chemotherapy for Prostate Cancer — the Experience of the National Prostatic Cancer Project (1985) (2)
- Role of nurse clinician in urologic oncology. (1978) (2)
- 698 EVALUATION OF NON-NEOPLASTIC RENAL PARENCHYMA IN PARTIAL NEPHRECTOMY SPECIMENS (2011) (2)
- POD-07.04 Active Surveillance for Prostate Cancer: An Update on the Miami Experience (2011) (2)
- Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasia (1993) (2)
- En bloc mobilization of the inferior vena cava and large hypervascular right renal tumors with or without inferior vena cava thrombus: Posterior ligation of the renal artery (2006) (2)
- Neoadjuvant hormonal treatment before radical prostatectomy. (1996) (2)
- Effect of concentration and time of drug exposure on clonal growth of murine bladder cancer. (1985) (2)
- Abdominal Pain, Left Retroperitoneal Mass and Right Renal Mass in a 62-Year-Old Man (1984) (2)
- Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma (2022) (2)
- Active Surveillance with Delayed Intervention for Recurrent Low Risk Bladder Cancer (2015) (2)
- Bladder Cancer: Clinical Aspects and Management (1998) (2)
- 383 Hyaluronic Acid and Hyal1 Hyaluronidase: Prognostic Markers for Bladder Cancer (2007) (2)
- Role of induction androgen deprivation before radical prostatectomy. (1995) (2)
- Review Article INCIDENCE7 ETIOLOGY7 LOCATION7 PREVENTION AND TREATMENT OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER (1998) (2)
- Chapter 18 – Superficial Transitional Cell Carcinoma of the Bladder: Management and Prognosis (2005) (2)
- Orthotopic ileal neobladder reconstruction for bladder cancer: is adjuvant chemotherapy safe? (2006) (2)
- The emerging role of epigenetics in urological cancers. (2007) (2)
- The management of incidental T1aG1 (TNM 1987) prostate cancer (1992) (2)
- Systemic therapy for superficial bladder cancer. (1984) (2)
- Prostate capsule sparing radical cystectomy – a safe procedure for few (2016) (2)
- High-dose ketoconazole in castration-resistant, metastatic prostate cancer patients previously treated with docetaxel chemotherapy: Single institution retrospective review. (2010) (2)
- Evaluation of cystography for detection of bladder carcinoma in mice: comparison with urinary cytology. (1981) (2)
- Comparison between a purified and standard diet on FANFT-induced murine bladder cancer. (1981) (2)
- Panel V: Distant disease (1992) (2)
- Systemic mitomycin C versus cisplatin: comparison of antitumor activity in primary murine bladder cancer. (1982) (2)
- Intravesical mitomycin C in superficial bladder cancer (1981) (2)
- Adenocarcinoma of the prostate. Stage-by-stage treatment alternatives. (1988) (2)
- 632: Prognostic Significance of Venous Thrombus in Renal Cell Carcinoma: A Multiinstitutional Study (2007) (1)
- 573: Radical Cystectomy in Hispanic Patients: An Outcome Analysis (2007) (1)
- Editorial comment. (2005) (1)
- Effect of media and growth promoters on in vitro cultivation of normal murine urinary bladder epithelium. (1982) (1)
- Nephrogenic adenoma. (1985) (1)
- The role of radical prostatectomy in patients with PSA of 20 or greater and/or a prostate biopsy with a total Gleason sum of 8 or greater (2000) (1)
- Cisplatin, Neoadjuvant Chemotherapy and Bladder Cancer. (2021) (1)
- Challenging Cases in Urothelial Cancer (2016) (1)
- Treatment of prostatic cancer. Newer forms of androgen deprivation. (1986) (1)
- Urothelial trauma — A mechanism of tumor promotion? (1983) (1)
- Superficial bladder disease: case studies and therapeutic advances. (1992) (1)
- 669 ACTIVE SURVEILLANCE FOR FAVORABLE-RISK PROSTATE CANCER: AN UPDATE OF THE UNIVERSITY OF MIAMI PROGRAM (2013) (1)
- Review Article SURGICAL TECHNIQUES FOR TREATING A RENAL NEOPLASM INVADING THE INFERIOR VENA CAVA (2003) (1)
- Clinicopathological conference. Abdominal pain, left retroperitoneal mass and right renal mass in a 62-year-old man. (1984) (1)
- POD-07.01: Hexaminolevulinate New Data: Results from the Recurrence Study (2009) (1)
- Re: Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients: S. Picozzi, C. Ricci, M. Gaeta, D. Ratti, A. Macchi, S. Casellato, G. Bozzini and L. Carmignani. J Urol 2012; 188: 2046-2054. (2013) (1)
- 1668 LONG-TERM CLINICAL BENEFIT OF HEXAMINOLEVULINATE ENABLED FLUORESCENCE CYSTOSCOPY (2012) (1)
- Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancer. (1990) (1)
- 533 CURRENT PRACTICE GAPS IN THE USE OF BCG MAINTENANCE: RESULTS OF THE INTERNATIONAL PATIENT DATA SURVEY (2012) (1)
- Pathology examination cannot be done without a urologist's help (2014) (1)
- BCG for high grade NMIBC - Lessons learned over 40 years. (2017) (1)
- The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer: Reply by authors (1999) (1)
- Basal cell carcinoma of the prostate: A case report and review of the literature (2009) (1)
- 671 DEVELOPMENT AND MULTI-INSTITUTIONAL VALIDATION OF A BIOPSY-INTEGRATED ALGORITHM FOR DETERMINING GLEASON 6 UPGRADING RISK (2013) (1)
- PROSTATE RADIOTHERAPY: WHAT IS THE CONTEMPORARY RISK OF BLADDER AND RECTAL CARCINOMA? (2008) (1)
- AGE AS A PROGNOSTIC FACTOR FOLLOWING RADICAL RETROPUBIC PROSTATECTOMY (1999) (1)
- Radiation therapy and cis-diamminedichloroplatinum (II) (DDP) in transplantable and primary murine cancer (1978) (1)
- Bladder cancer--Part III. (1980) (1)
- Re: urinary continence and pathological outcome after bladder neck preservation during radical retropubic prostatectomy: a randomized prospective trial. (2001) (1)
- Re: The use of enoxaparin to prevent venous thromboembolism in patients undergoing radical retropubic prostatectomy: feasibility and utility. (2007) (1)
- MP-13.06 Complications of Open Radical Prostatectomy: More Than 18 Years Experience at One Center (2011) (1)
- 1747 PROGNOSTIC SIGNIFICANCE OF CYSTOSCOPY FINDINGS FOLLOWING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER (2012) (1)
- Radical retropubic prostatectomy: Contemporary modifications (2008) (1)
- Enhancement of high intensity Iodine-125 brachytherapy by cis-platinum in a murine bladder tumor model. (1984) (1)
- Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points (2021) (1)
- Potential effects of edema on the pharmacokinetics of platinum in patients treated with cis-dichlorodiammine platinum (II). (1980) (1)
- Correlation of drug sensitivity of FANFT induced mouse bladder tumors grown in syngeneic mice, in soft agar, and in microtiter plates (1981) (1)
- Long term chemotherapy and/or immunotherapy of primary murine bladder cancer. Abstr. (1976) (1)
- [Experimental intravesical treatment of bladder tumor with Concanavalin-A conjugated bleomycin]. (1984) (1)
- Simple Grading System for Bone Scans Correlates with Survival for Patients with Stage D 2 Prostate Cancer (1987) (1)
- Bladder cancer – How to improve? (2013) (1)
- Case profile: horseshoe kidney with calculi in patient with sarcoidosis. (1976) (1)
- Re: renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. (2005) (1)
- Clinical Scenario: Microscopic Hematuria and Atypical Cytology (2015) (1)
- 1242: Lack of Progress in the Early Diagnosis of Bladder Cancer (2006) (1)
- Patient selection for maximal androgen deprivation (1993) (1)
- T1 and T2 Bladder Cancer: Selecting Optimal Therapy (1998) (1)
- Left-Sided Inferior Vena Cava with Renal Carcinoma: A Case Report (2009) (1)
- Redistribution of age-specific prostate cancer stage at diagnosis (1997) (1)
- 1025: PSA Recurrence Rates are Low After Radical Retropubic Prostatectomy and Positive Margins (2005) (1)
- Editorial Comments: Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the Bladder (1995) (1)
- Cytoxan, adriamycin, and 5 fluorouracil combination chemotherapy in advanced carcinoma of the prostate (1977) (1)
- The effect of platinum analogues and combination chemotherapy on murine bladder cancer. (1979) (1)
- Possible malignancy after cytology analysis in a 45-year-old man (2008) (1)
- Hyaluronidase : A Negative Regulator of Bladder Cancer HYAL 1v 1 , An Alternatively Spliced Variant of HYAL 1 (2006) (1)
- 191: Does the Body Mass Index Affect the Outcome Following Reconstruction of Orthotopic Neobladder? (2007) (1)
- Transitional Cell Carcinoma of the Prostatic Urethra Following Intravesical Therapy (1987) (1)
- Treatment of Advanced Bladder Cancer (1985) (1)
- A Case for Risk-adapted Management of Low-grade Bladder Tumors. (2020) (1)
- 890: Hyaluronic Acid and HYAL1 Hyaluronidase: Predictors of Bladder Cancer Prognosis (2007) (1)
- 191 STANDARDIZED REPORTING OF POSITIVE SURGICAL MARGIN STATUS IN RADICAL PROSTATECTOMY SPECIMENS: A NOVEL OUTCOME PREDICTING SCORING SYSTEM (F.U.S.E. SCORE) (2012) (1)
- 1120: Radical Cystectomy after BCG: Are we Waiting Too Long? (2005) (1)
- Editorial Comment: The Significance of Central Pathology Review in Clinical Studies of Transitional Cell Carcinoma in Situ (1997) (0)
- Editorial Commentary (2019) (0)
- Prostatic cancer: A three-article symposium (1986) (0)
- Ct2 Bladder Cancer (2016) (0)
- Case report: Primary hyperparathyroidism coincident with metastatic carcinoma of the prostate. (1980) (0)
- Bladder cancer. (1996) (0)
- Aberrant promoter methylation in serum of prostate cancer patients and controls. (2009) (0)
- Editorial comment. (2009) (0)
- 1754 DOES AGE INFLUENCE THE DEVELOPMENT OF URINARY INCONTINENCE IN PATIENTS WHO ARE CONTINENT FOLLOWING TOTAL PROSTATECTOMY (2010) (0)
- Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: Final evaluation of a prospective multicenter study with 419 patients: Editorial comment (II) (1990) (0)
- 1517: Radical Cystectomy for Bladder Cancer Secondary to Radiation for Carcinoma Prostate - IS it Associated with Poorer Prognosis? (2007) (0)
- Value of renography following radical pelvic cancer surgery (1972) (0)
- POD-03.03: Surgical management and outcome of renal cell carcinoma with level III IVC thrombus: a single center experience (2007) (0)
- 963 DIAGNOSIS, METASTASIS AND RECURRENCE OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER ARE ASSOCIATED WITH EXPRESSION OF HYALURONIC ACID REGULATORS (2010) (0)
- How should we understand the term androgen deprivation therapy? (2012) (0)
- Recurrence of prostate cancer after radical prostatectomy in a 57-year-old man (2008) (0)
- 1745 COMPARISON OF UROLOGIST REIMBURSEMENT FOR MANAGING PATIENTS WITH LOW RISK PROSTATE CANCER BY ACTIVE SURVEILLANCE VERSUS TOTAL PROSTATECTOMY (2010) (0)
- Squamous cell carcinoma with lamina propria invasion in an 84-year-old physician who prefers to avoid total cystectomy (2008) (0)
- Inflammatory changes and the prostate (2013) (0)
- Challenging Cases in Urothelial Cancer (2018) (0)
- Abstract 5174: HYAL4: a new player in bladder cancer progression and diagnosis (2011) (0)
- 1410: Active Surveillance with Delayed Intervention for Localized Prostate Cancer: University of Miami Experience (2007) (0)
- The comparison of a murine versus a clonogenic assay for determining chemotherapeutic drug sensitivity of fanft induced murine bladder tumor lines. Abstr. (1982) (0)
- 606 PROGNOSTIC SIGNIFICANCE OF HYALURONIC ACID FAMILY FOR METASTATIC RENAL CELL CARCINOMA (2013) (0)
- Reply to authors. (2014) (0)
- Re: serial multiple-site biopsies in patients with bladder cancer. (1979) (0)
- MP26-15 TREND IN TA STAGE UROTHELIAL CARCINOMA OF THE BLADDER: SHIFT TO HIGHER GRADING? (2015) (0)
- Current concepts in the management of superficial bladder cancer. (1990) (0)
- Words of wisdom. Re: Intraoperative thrombus embolization during nephrectomy and tumor thrombectomy: critical analysis of the University of California-Los Angeles experience. (2009) (0)
- MP-13.07 Surgical Margin Status is not Associated with Overall Survival After Radical Prostatectomy (2011) (0)
- Urothelial neoplastic cellular implantation--intravesical and systemic chemotherapeutic prophylaxis. Abstr. (1975) (0)
- Young man with locally advanced prostate cancer (2007) (0)
- 1607: Concurrent Inguinal Hernia Repair and Radical Retropubic Prostatectomy through a Single Modified Pfannenstiel Incision: 3 Year Experience (2006) (0)
- Challenging Cases in Urothelial Cancer (2018) (0)
- 1662: Contiguous and Non-Contiguous Prostatic Urethral Transitional Cell Carcinoma- does It Impact the Survival? (2007) (0)
- Morbidity of modified pelvic lymphadenectomy and external beam radiation therapy for prostatic cancer. (1990) (0)
- Cis-Diamminedichloroplatinum (II) in Locally Advanced and Metastatic Urothelial Cancer (1982) (0)
- The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. (1978) (0)
- Comprar Nephron-Sparing Surgery | K. Sasidharan | 9781841846361 | Informa Healthcare (2007) (0)
- A 43-year-old African American man with low-risk prostate cancer (2008) (0)
- 1740 DOES ERECTILE DYSFUNCTION DRIVE DECISIONS REGARDING ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2010) (0)
- 558: Factors Affecting Potency Following Radical Retropubic Prostatectomy: Results from 1620 Consecutive Patients (2007) (0)
- Urinary incontinence: A four-article symposium (1988) (0)
- A URINE-BASED REAL TIME RT-PCR ASSAY FOR HYAL1 HYALURONIDASE AND HA-SYNTHASE TO DETECT BLADDER CANCER (2008) (0)
- Rationale for intensive intravesical chemotherapy. (1984) (0)
- MP-18.16: Modified transverse Pfannenstiel and vertical minilaparotomy incisions provide excellent exposure, minimal perioperative pain, and excellent cosmesis in patients undergoing radical retropubic prostatectomy (2007) (0)
- 356 CAN WE ACCURATELY PREDICT “INSIGNIFICANT” PROSTATE CANCER? EXTERNAL VALIDATION AND HEAD-TO-HEAD COMPARISON OF THE EXISTING NOMOGRAMS (2012) (0)
- renal artery pseudoaneurysm following open partial (2009) (0)
- Incomplete prostatectomy for cancer (2009) (0)
- MOLECULAR SUBTYPES IN MUSCLE INVASIVE BLADDER CANCER: EVALUATION OF CLINICAL SIGNIFICANCE: MP58‐01 (2018) (0)
- Urinary incontinence. Introduction. (1988) (0)
- Words of wisdom. Re: Venous resection in urologic surgery. (2009) (0)
- POD-09.05: Is neo-adjuvant chemotherapy better tolerated than adjuvant chemotherapy in patients undergoing cystectomy? (2007) (0)
- Conclusions: Dr. Soloway (2008) (0)
- Editorial Comment. (2018) (0)
- We are not yet ready to abandon cystoscopy (2007) (0)
- Nephron-Sparing Surgery (2007) (0)
- 447 MIRNA EXPRESSION IN RENAL CELL CARCINOMA SUBTYPES IDENTIFYING ONCOCYTOMA (2012) (0)
- TRANSITIONAL CELL CARCINOMA OF THE PROSTATE. AUTHOR REPLY (1992) (0)
- SDCT2 AS A FUNCTIONAL BIOMARKER OF RENAL CELL CARCINOMA: MP39‐15 (2017) (0)
- Commentary (Soloway): Morbidity of Contemporary Radical Retropubic Prostatectomy for Localized Prostate Cancer (1995) (0)
- 1829 RADICAL CYSTECTOMY AFTER BCG: HAS THE TIMING OF SURGERY IMPROVED IN RECENT YEARS? (2010) (0)
- MP68-02 IMPACT OF 2004 ISUP—WHO CLASSIFICATION ON BLADDER CANCER GRADING AND POTENTIAL IMPACT ON TREATMENT (2015) (0)
- A 49-year-old Hispanic male with intraepithelial neoplasia and focal atypia (2008) (0)
- OUTCOMES OF pT0 AT RADICAL CYSTECTOMY WITHOUT NEOADJUVANT THERAPY (2008) (0)
- HYAL4: A NEW PLAYER IN BLADDER CANCER PROGRESSION AND DIAGNOSIS (2009) (0)
- Patient tolerability during office cystoscopy and bladder tumor cauterization: a multivariate analysis of risk factors. (2022) (0)
- New markers for testicular non-seminoma and seminoma: HA and HAS-1 (2003) (0)
- CONTEMPORARY OPEN NEPHRON SPARING SURGERY IS ASSOCIATED WITH DIMINISHED PERIOPERATIVE MORBIDITY, DESPITE MORE CHALLENGING SURGERY (2009) (0)
- A rapid tumor marker assay detects NMP22 in urine (2005) (0)
- 1890 HISTOPATHOLOGICAL EVALUATION OF BLADDER CANCER IS RELIABLE EVEN ON AN INTERCONTINENTAL SCALE: COMPARISON OF LOCAL AND CENTRALLY REVIEWED HISTOPATHOLOGY FOR A MULTICENTER INTERCONTINENTAL TRIAL (2011) (0)
- 1411: 10-Year Outcome after Radical Prostatectomy for Pathologic Gleason Score ≥ 8 (2007) (0)
- Re: Williams et al.: Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s) (Urology 2010;76:1097-1101). (2011) (0)
- Medroxyprogesterone in metastatic renal cell carcinoma. (1980) (0)
- [Contribution of surgical techniques used in liver transplantation in the treatment of retroperitoneal tumors]. (2001) (0)
- 556: Type of Urinary Diversion. Patient-Physician Dialogue? (2006) (0)
- Editorial Comment: Deoxyribonucleic Acid Ploidy and the Clinical Pattern of Grade 2 Superficial Bladder Cancer (1997) (0)
- 2102 PROSTATE-SPECIFIC ANTIGEN KINETICS AND BIOPSY PROGRESSION IN PATIENTS MANAGED BY ACTIVE SURVEILLANCE (2012) (0)
- Lower Tract Urothelial CancerReply (2010) (0)
- 89 Comparison of prognostic indicators HA, HYAL1, CD44V6 and microvessel density for prostate cancer: A 5-year retrospective study (2004) (0)
- In Reply: Re: Quality of Life: Radical Prostatectomy Versus Radiation Therapy for Prostate Cancer (1996) (0)
- 1710 ARE COMPLETION RATES BETTER FOR NEOADJUVANT COMPARED TO ADJUVANT CHEMOTHERAPY IN PATIENTS UNDERGOING RADICAL CYSTECTOMY (2010) (0)
- EAU and AUA/SUO Guidelines on Risk Categories for Non-Muscle Invasive Bladder Cancer May Lead to Overtreatment for Low Grade Ta Bladder Tumors (2017) (0)
- Should all superficial bladder tumors be treated with intravesical therapy? (1989) (0)
- A 79-year-old man with urothelial carcinoma of the bladder and upper urinary tract (2007) (0)
- 1339 THE OUTCOMES OF ACTIVE SURVEILLANCE CANDIDATES WHO UNDERWENT RADICAL PROSTATECTOMY IMMEDIATELY AFTER DIAGNOSIS (2013) (0)
- 572: Radical Cystectomy in Octogenarian: Is Routine Post Operative Intensive Care Monitoring Necessary? (2007) (0)
- Urinary tract infection and a small stone (2007) (0)
- 1839 PREOPERATIVE MANAGEMENT IS NOT ASSOCIATED WITH GENDER-RELATED DIFFERENCES IN SURVIVAL AFTER RADICAL CYSTECTOMY (2011) (0)
- 1333 AFRICAN AMERICAN MEN WITH LOW-RISK PROSTATE CANCER MAY HAVE INCREASED RISK OF PROGRESSION ON ACTIVE SURVEILLANCE (2012) (0)
- FANFT-induced bladder tumors. (1976) (0)
- The Fallacy of "Definitive Therapy" for Prostate Cancer. (2020) (0)
- EXPRESSION AND FUNCTION OF A NOVEL CHONDROITINASE IN BLADDER CANCER: MP48‐01 (2017) (0)
- Editorial comment. With many other neoplasms, bladder cancer is heterogeneous. (2009) (0)
- Challenging Case: Stones (2016) (0)
- POS-03.59: Prospective randomized trial comparing transverse (pfannenstiel) and vertical incisions for patients undergoing radical retropubic prostatectomy (2007) (0)
- Editorial comments to paper published in this issue on pgs. 152-155 (2011) (0)
- Urothelial Carcinoma of the Lower Urinary Tract: Introduction (2009) (0)
- Low-risk prostate cancer and low testosterone: What are the acceptable alternatives? (2009) (0)
- 673 A NOMOGRAM PREDICTING THE RISK OF PROGRESSION IN PATIENTS MANAGED BY ACTIVE SURVEILLANCE (2013) (0)
- Time dependent inhibition of mouse bladder tumor (MBT) colony survival by cisplatinum (DDP) in a human tumor stem cell assay (HTSA) (1981) (0)
- Editorial comment. (2010) (0)
- 2119 CONCORDANCE BETWEEN BIOPSY AND PATHOLOGY GLEASON SCORES DEPENDS ON TUMOR LOCATION IN THE PROSTATE (2011) (0)
- A small mass in a single testis after orchiectomy for testis cancer (2008) (0)
- POD-07.03 Pathology Results of Radical Prostatectomy in Patients Initially Managed by Active Surveillance (2011) (0)
- Challenging Cases in Urothelial Cancer (2017) (0)
- 1246: Orthotopic Neobladder Reconstruction Following Cystectomy for Bladder Cancer: Is Adjuvant Chemotherapy Safe? (2006) (0)
- Challenging Cases in Urothelial Cancer (2018) (0)
- Challenging Cases in Urothelial Cancer1 (2020) (0)
- 829 IMPACT OF BMI AND TUMOR LOCATION ON THE INCIDENCE OF BENIGN HISTOLOGY AT THE TIME OF NEPHRON- SPARING SURGERY FOR T1 RENAL MASSES (2010) (0)
- Postoperative intravesical chemotherapy has an important role in reducing subsequent bladder tumours – why is it not routine? (2018) (0)
- hemotherapy for Bladder Cancer : reatment Guidelines for Neoadjuvant hemotherapy , Bladder Preservation , djuvant Chemotherapy , and Metastatic ancer (2007) (0)
- 1354 CHEMOKINE SDF1-B AND RECEPTOR CXCR7: FUNCTIONALLY ASSOCIATED MOLECULAR MARKERS FOR BLADDER CANCER DIAGNOSIS AND PROGNOSIS (2011) (0)
- Managing and Preventing Progression in Patients with Mid- to High-Risk Bladder Cancer: A Case Study Approach (2006) (0)
- The Use of an Animal Model to Gain Insights into Bladder Cancer Therapy (1985) (0)
- Concepts in the Treatment of Bladder Cancer - Clinical and Experimental (1982) (0)
- REGULATION OF BLADDER TUMOR MARKER, HYAL1 HYALURONIDASE: IMPLICATIONS IN DIAGNOSIS AND THERAPY (2008) (0)
- Effect of regional lymphadenectomy on development of concomitant immunity. (1972) (0)
- MP71-05 MOLECULAR SUBTYPING OF RCC AND METASTASIS PREDICTION BY MIRNA EXPRESSION (2016) (0)
- Challenging Cases in Urothelial Cancer (2017) (0)
- Examining the location and the cause of death within 30 days of radical prostatectomy (2005) (0)
- MP-18.08: Incidental prostatic neoplasia in patients undergoing radical cystoprostatectomy: does it affect the overall prognosis? (2007) (0)
- Distant disease. (1992) (0)
- Watchful waiting policy in recurrent Ta G1 bladder tumors: Commentary (2006) (0)
- Editorial comment. Focal positive surgical margins decrease disease-free survival after radical prostatectomy even in organ-confined disease. (2010) (0)
- Challenging Cases in Urothelial Cancer: Case 181 (2020) (0)
- Re: Venous Resection in Urologic Surgery (2009) (0)
- Comment on: Can Restaging Transurethral Resection of T1 Bladder Cancer Select Patients for Immediate Cystectomy? Authors' reply (2007) (0)
- Challenging Cases in Urothelial Cancer (2017) (0)
- Challenging Cases in Urothelial Cancer (2017) (0)
- 115 MOLECULAR CHARACTERIZATION OF RENAL CELL CARCINOMA AND ONCOCYTOMA (2011) (0)
- Challenging Cases in Urothelial Cancer: Case 20 (2021) (0)
- 1238: Evaluation of Risk for Muscle Invasive and High Grade Bladder Cancer Using A Point-of-Care Assay (2006) (0)
- 636 CHANGES IN QUALITY OF LIFE OVER TIME POST-RADICAL CYSTECTOMY DEPEND ON URINARY DIVERSION TYPE (2011) (0)
- 71 MOLECULAR TARGETS IN KIDNEY CANCER (2010) (0)
- Operative Urology at the Cleveland Clinic, A.C. Novick, J.S. Jones, I.S. Gill, E.A. Klein, R. Rackley, J.H. Ross. Humana Press, Totowa, New Jersey (2006), 576 pages (2007) (0)
- Bladder cancer, prostate cancer, and benign prostatic hyperplasia (1994) (0)
- 332: Transitional Cell Carcinoma of the Prostatic Urethra: Long Term Outcome After Radical Cystoprostatectomy (2004) (0)
- Re: can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? H. W. Herr, S. M. Donat and G. Dalbagni J Urol 2007; 177: 75-79. (2007) (0)
- MP46-04 GLEASON SCORE AT THE SURGICAL MARGIN AND THE RISK OF BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY (2014) (0)
- Dynamic Contrast Enhanced MRI for the Identification of Prostate Cancer in the Prostate Bed After Radical Prostatectomy (2011) (0)
- High-grade T1 bladder cancer at the ureterovesical junction (2007) (0)
- Marı́a José Ribal et al. Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial (2007) (0)
- TRANSITIONAL-CELL CARCINOMA* (1974) (0)
- Local tumor recurrence following "radical prostatectomy". (1992) (0)
- The plight of the cancer patient--the double-edged sword. (1983) (0)
- Words of wisdom. Re: Temporary balloon occlusion of the inferior vena cava in resection of renal tumor with vena cava thrombus extension. (2009) (0)
- 366 IS PARTIAL SAMPLING OF A RADICAL PROSTATECTOMY SPECIMENS ASSOCIATED WITH MISSING OF POSITIVE MARGINS OR EXTRAPROSTATIC EXTENSIONS (2012) (0)
- Two new techniques for evaluating prostate cancer. The role of prostate-specific antigen and transrectal ultrasound. (1989) (0)
- Panel Discussion II (1996) (0)
- 1664 BUDD-CHIARI SYNDROME IN UROLOGY: IMPACT ON NEPHRECTOMY FOR ADVANCED RENAL CELL CARCINOMA (2010) (0)
- 1108: Comparison of Prognostic Indicators HA, HYAL1, CD44V6 and Microvessel Density for Prostate Cancer: A 5-Year Retrospective Study (2004) (0)
- Abstract A71: Perceived stress management skills and quality of life in ethnic minority men newly diagnosed with prostate cancer (2010) (0)
- The management of urothelial cancer in 2010 and beyond (2011) (0)
- Serum-free circulating DNA as a biomarker of prostate cancer diagnosis. (2010) (0)
- Incorporation of M-VAC combination chemotherapy in the treatment of patients with invasive and metastatic bladder cancer. (1988) (0)
- 695 THE TOTAL NUMBER OF POSITIVE CORES IN DIAGNOSTIC AND REPEAT BIOPSIES IS STRONGLY ASSOCIATED WITH THE RISK OF PROGRESSION IN PROSTATE CANCER PATIENTS MANAGED BY ACTIVE SURVEILLANCE (2012) (0)
- 1748 ONCOLOGICAL AND FUNCTIONAL OUTCOME FOLLOWING TOTAL PROSTATECTOMY: HOW MANY MEN ACHIEVE THE “TRIFECTA”? (2010) (0)
- 985: HAS1 Expression in Bladder Cancer and its Real Tion to Urinary HA Test (2006) (0)
- Surveillance and office management of low-grade Ta bladder tumors. (2022) (0)
- Words of wisdom. Re: Adjuvant radiotherapy following radical prostatectomy for prostate cancer. (2012) (0)
- The management of superficial bladder cancer. (1980) (0)
- Commentary (Soloway): Management of Patients With Muscle-Invasive and Metastatic Bladder Cancer (2005) (0)
- Challenging Cases in Urothelial Cancer: Case 171 (2020) (0)
- M-VAC regimen in murine bladder tumors. (1989) (0)
- 1736 SERUM FREE CIRCULATING DNA AS A BIOMARKER FOR PROSTATE CANCER DIAGNOSIS (2010) (0)
- LONG TERM SURVIVAL IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY AND INFERIOR VENA CAVA THROMBECTOMY: SINGLE CENTER EXPERIENCE (2009) (0)
- Modified Pfannenstiel approach for radical retropubic prostatectomy. Authors' reply (2005) (0)
- MP-16.22: Contemporary open nephron sparing surgery offers excellent tumor control with significantly diminished perioperative morbidity (2007) (0)
- PD-11.01 (2006) (0)
- Legends of urology. (2009) (0)
- Pelvic Hematoma Due to Anticoagulant Therapy Causing Urethro-Vesical Anastomosis Disruption After Radical Prostatectomy: A Case Report (2014) (0)
- Comment on: Prognosis of muscle-invasive bladder cancer: Difference between primary and progressive tumours and implications for therapy. Author's reply (2005) (0)
- Bladder cancer: Brachytherapy-based bladder sparing alternative to cystectomy (2009) (0)
- Editorial Comment: The Effect of Intravesical Mitomycin C on Recurrence of Newly Diagnosed Superficial Bladder Cancer (1996) (0)
- SLC13A3 as a functional biomarker and determinant of racial discrepancies in renal cell carcinoma (2018) (0)
- Diagnostic ( MBMD ) Predicts Health-related Quality of Life ( HrQoL ) Over Time Among Men Treated for Localized Prostate Cancer (2019) (0)
- Preparation for Prostate Biopsy (2008) (0)
- DOES NOCTURNAL INCONTINENCE AFFECT THE HEALTH RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH ORTHOTOPIC ILEAL NEOBLADDER (2008) (0)
- Nephron-sparing surgery: history and evolution (2007) (0)
- Challenging Cases in Urothelial Cancer (2018) (0)
- Role of selected mucosal biopsies in the evaluation of patients with bladder cancer. (1984) (0)
- [Bladder tumors]. (1986) (0)
- Reply to Roberto Mario Scarpa and Cecilia Maria Cracco’s Letter to the Editor re: Alan M. Nieder, Mark S. Soloway. It’s Not a Radical Prostatectomy, It’s a Total Prostatectomy. Eur Urol 2008;54:715–6 (2010) (0)
- INSIGHTS INTO BLADDER CANCER THERAPY (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mark S. Soloway?
Mark S. Soloway is affiliated with the following schools:
